Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells

Cited by papers we hold 5

• The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism · 2023
  No notice
• Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target · 2021
  No notice
• The Role of mTOR Signaling as a Therapeutic Target in Cancer · 2021
  No notice
• Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma · 2020
  No notice
• DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.